A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Medical College of Wisconsin
Washington University School of Medicine
University of California, San Francisco
Duke University
Stanford University
Stanford University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Stanford University
French Innovative Leukemia Organisation
Washington University School of Medicine
Texas Oncology Cancer Center
SWOG Cancer Research Network
SWOG Cancer Research Network
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Pediatric Brain Tumor Consortium
Methodist Healthcare